| Literature DB >> 1846920 |
J E Francis1, W D Cash, B S Barbaz, P S Bernard, R A Lovell, G C Mazzenga, R C Friedmann, J L Hyun, A F Braunwalder, P S Loo.
Abstract
Investigation of tricyclic heterocycles related to the 2-arylpyrazolo[4,3-c]quinolin-3(5H)-ones, structures with high affinity for the benzodiazepine (BZ) receptor, led to the synthesis of 2-phenyl-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one, a compound with 4 nM binding affinity to the BZ receptor. Analogues were prepared to assess the importance of the 2-substituent and ring substitution in modifying activity. Several novel synthetic routes were designed to prepare the target compounds, including a two-step synthesis beginning with an anthranilonitrile and a hydrazide. Of the 34 compounds screened in this series, three compounds were found to be potent BZ antagonists in rat models. The leading compound, 9-chloro-2-(2-fluorophenyl) [1,2,4]triazolo[1,5- c]quinazolin-5(6H)-one (CGS 16228), showed activity comparable to that of CGS 8216 from the pyrazolo[4,3-c]quinoline series.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1846920 DOI: 10.1021/jm00105a044
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446